MarshNYSE: MRSH
Financials · Insurance Brokers
$167.48
+1.43%
Vol: 163K
Research Digest
Monday, June 15, 2026
No significant overnight updates
No material news in the last 48 hours.
Previous Market Intelligence
13 daysJun 14No significant overnight updatesNeutral▶
No material news in the last 48 hours.
May 21No significant overnight updatesNeutral▶
No material news in the last 48 hours.
May 20Marsh McLennan's Oliver Wyman announced senior leadership changes on May 7 to accelerate AI-enabled transformation, while director RSU activity and steady fundamentals dominate recent disclosures.Neutral▶
On May 7, 2026, Marsh's Oliver Wyman unit announced senior leadership appointments aimed at accelerating AI-enabled integration and transformation across the consulting business. On May 6, Mercer and Syndio announced a partnership to bridge compensation strategy and pay decisions. Marsh Risk also unveiled two new AI-powered Risk Companion solutions (Renewal Companion and Captive Companion) at RIMS RISKWORLD 2026 in Philadelphia (May 3-6). Multiple director Form 4 filings disclosed RSU grants and dividend-equivalent credits in mid-May. Q1 2026 results released earlier showed consolidated revenue up 8% YoY to $7.6B and adjusted EPS of $3.29 (up 8%), with management reaffirming full-year guidance for similar underlying revenue growth, margin expansion, and solid adjusted EPS growth. Analyst consensus is Hold with average targets in the $206-$211 range; the stock trades near $173.
May 19Marsh & McLennan filed a trademark application for 'MARSH RE' (published May 1, 2026), signaling potential reinsurance branding expansion, while Citigroup upgraded the shares to Buy from Neutral on May 6.Mixed▶
Marsh & McLennan's trademark application for 'MARSH RE' became public on May 1, 2026, suggesting a strategic move to formalize a dedicated reinsurance brand within its Marsh broking franchise. On May 6, 2026, Citigroup upgraded MMC/MRSH from Neutral to Buy. The company recently changed its primary ticker reference from MMC to MRSH. Shares traded $160.96-$163.26 on May 15, with the analyst average price target at $211.15 against a Hold consensus from 13 analysts. A quarterly cash dividend of $0.90 per share was payable May 15 to holders of record April 9. The bear case: the Q1 earnings call already flagged pricing pressure across insurance broking, and shares have drifted lower into mid-May despite the Citi upgrade, suggesting investors remain cautious about organic revenue growth as commercial insurance rate momentum decelerates.
May 18Marsh McLennan won a Citi upgrade to Buy and launched AI-powered Risk Companion tools ahead of the May 21 annual meetingPositive▶
On May 6, 2026 Citigroup upgraded Marsh & McLennan from Neutral to Buy, citing the company's resilience and outlook. At RIMS RISKWORLD 2026 in Philadelphia (May 3-6), Marsh Risk unveiled two AI-powered Risk Companion solutions - Renewal Companion for modeling coverage scenarios and Captive Companion for monitoring captive insurance financial metrics. The 2026 proxy outlines a virtual annual meeting on May 21, 2026 to elect 13 directors, hold an advisory vote on executive pay, and ratify Deloitte & Touche as auditor. A $0.900 quarterly cash dividend was payable May 15, 2026 to shareholders of record April 9. Q1 2026 consolidated revenue rose 8% YoY to $7.6 billion with adjusted EPS of $3.29, also up 8%. 13-analyst consensus is Hold with a $211.15 price target. Some sources note the ticker may now appear as MRSH.
May 15Marsh McLennan (now trading as MRSH) saw 13-F filings on May 12-13 with Securian cutting its stake 43.9% while Swiss Life raised its position 9.5%.Neutral▶
Marsh & McLennan (ticker MRSH as of January 2026 rebrand) had institutional filings reported May 12-13: Securian Asset Management cut holdings 43.9% in Q4 while Swiss Life Asset Management lifted its stake 9.5%. No fresh material corporate news in the last 24-48 hours; recent context includes the broader Marsh rebrand effective January 2026 and the Marsh McLennan Agency acquisition of TriBridge Partners. Q1 2026 results previously beat with EPS $3.29 vs $3.21 and revenue up 7.6% to $7.30B. Risk: institutional sentiment is mixed as evidenced by divergent positioning.
May 14Marsh & McLennan hits new 52-week low at $161.38 even as Citigroup upgrades to Buy and Oliver Wyman expands via acquisitionMixed▶
Marsh & McLennan shares hit a fresh 52-week low of $161.38 on May 12 despite a string of positive corporate actions. Citigroup upgraded the stock from Neutral to Buy with a $200 price target on May 6, and Oliver Wyman announced senior leadership appointments on May 7 to accelerate AI-enabled integration. Marsh Risk launched two new AI-powered Risk Companion solutions at RIMS RISKWORLD on May 3-6, including Renewal Companion and Captive Companion. A $0.90 quarterly dividend is payable May 15. The risk is that share weakness reflects ongoing pricing pressure in insurance brokerage and litigation overhang flagged in Q1, even as fundamentals show 8% Q1 revenue growth to $7.6 billion.
May 13Securian cuts Marsh & McLennan stake 43.9% as fund-flow disclosures hit while stock remains under pressure with 25.9% YoY decline.Mixed▶
SEC filings disclosed May 12 showed Securian Asset Management reduced its MRSH holdings by 43.9% in Q4, while Swiss Life Asset Management raised its stake by 9.5%. The stock has lagged badly, down 25.9% over one year despite a Q1 2026 EPS beat ($3.29 vs $3.21 expected) on revenue of $7.30B (+7.6% YoY). Recent strategic moves include a multi-year Formula 1 partnership as Official Risk Partner and Oliver Wyman creating senior AI leadership roles. Margin decline is testing the long-term profitability narrative, but employee growth to 95,000 (+5.56% YoY) supports capacity expansion.
May 12Citigroup upgrades Marsh McLennan to Buy on May 6 as Oliver Wyman names first Chief AI Officer and acquires CR3 Partners restructuring consultancy.Positive▶
Oliver Wyman, a Marsh business, named Jeremy Badman to a newly created Chief AI and Data Officer role alongside two other senior leadership appointments to scale AI-driven solutions. Oliver Wyman also agreed to acquire CR3 Partners, adding 62 staff to deepen restructuring, liquidity management and crisis response capabilities, with closing expected later in the quarter. Citigroup upgraded MMC from Neutral to Buy on May 6. Marsh Risk unveiled AI-powered Risk Companion and Captive Companion solutions at RIMS RISKWORLD 2026 (May 3-6) in Philadelphia. Hillhouse Investment agreed to acquire Mercer's Asia-led Private Client Services business on May 8. The company has a market capitalization near $80B with a quarterly dividend of $0.90 payable May 15.
May 11Hillhouse Investment agreed on May 8 to acquire Marsh McLennan's Mercer Private Client Services unit, while Marsh launched new AI-powered Risk Companion tools at RIMS RISKWORLD 2026.Mixed▶
Marsh McLennan saw two notable developments in early May 2026. Hillhouse Investment agreed to acquire Mercer's Private Client Services, an Asia-led wealth protection and life insurance business, with the deal pending regulatory approvals. At RIMS RISKWORLD 2026 (May 3-6), Marsh Risk launched two AI-powered Risk Companion solutions for renewals and captives. Q1 2026 results showed revenue of $7.6 billion, up 8% YoY, and adjusted EPS of $3.29 (+8%), though a $425 million Greensill litigation charge weighed on reported profits. Shares trade near $167 with a $206 median analyst price target. The risk is Greensill-related liability exposure and softening insurance pricing.
May 8Marsh & McLennan reports Q1 2026 revenue of $7.6B (+8% YoY) despite $425M Greensill litigation chargeMixed▶
Marsh & McLennan reported strong Q1 2026 with revenue of $7.6B up 8% YoY and underlying revenue growth of 4%. However, the company recorded a $425M charge for resolving Greensill-related claims. Oliver Wyman announced three senior leadership appointments including Jeremy Badman as Chief AI and Data Officer. Marsh acquired TriBridge Partners and Oliver Wyman announced acquisition of CR3 Partners. Mercer and Syndio partnership closed on May 6. Company faces operational challenges from litigation but maintains strong core business growth and strategic capital deployment through acquisitions.
May 6Marsh & McLennan (MRSH) tops Q1 2026 revenue estimates; rebranding complete on NYSEPositive▶
Marsh & McLennan delivered Q1 2026 revenue of $7.6B (8% YoY, 4% organic) with adjusted EPS up 8% to $3.29. Risk & Insurance Services grew 3%, Consulting 5%, with Mercer raising $3.8B for private investments (April 2026). Company trades under new ticker MRSH (effective Jan 14, 2026) and reaffirmed 2026 guidance for similar organic growth and margin expansion. CFO McGivney named EVP/COO; strategic acquisitions ongoing (CR3 Partners, TriBridge). Dividend of $0.90/share declared. Average analyst PT is $199.27 (+20% from $166.18 price). Keefe Bruyette raised PT to $203 from $200.
May 5Marsh McLennan rebrands to Marsh, names new CEO for key divisionNeutral▶
Marsh & McLennan Companies (rebranded to Marsh effective January 2026, NYSE ticker changed to MRSH) reported strong Q1 2026 results on April 16. The company named Luca Zaramella as Chief Operating Officer and Chief Financial Officer, and appointed Ted Moynihan as CEO of Marsh Management Consulting and Oliver Wyman. Marsh priced $600 million of 4.950% Senior Notes due 2036. 2025 revenue was $26.98 billion, up 10.32% year-over-year.
Key Fundamentals
RSI (14-Day)
52-Week Range
Moving Averages
Price below 200d MA — bearish structure.